Article ; Online: Myeloid cell MHC I expression drives CD8
2024 Volume 14, Page(s) 1302006
Abstract: Background & aims: Activated CD8: Methods: We used H2Kb and H2Db deficient (MHC I KO: Results: In NASH, MHC class I isoform H2Kb was upregulated in myeloid cells. MHC I KO demonstrated protective effects against NASH-induced inflammation and ... ...
Abstract | Background & aims: Activated CD8 Methods: We used H2Kb and H2Db deficient (MHC I KO Results: In NASH, MHC class I isoform H2Kb was upregulated in myeloid cells. MHC I KO demonstrated protective effects against NASH-induced inflammation and fibrosis. Kb mice exhibited increased fibrosis in the absence of H2Db while LysM Kb KO mice showed protection against fibrosis but not inflammation. H2Kb restricted peptides identified a unique NASH peptide Ncf2 capable of CD8 Conclusion: These results suggest that activated hepatic CD8 |
---|---|
MeSH term(s) | Animals ; Mice ; Non-alcoholic Fatty Liver Disease/pathology ; CD8-Positive T-Lymphocytes ; Inflammation ; Myeloid Cells/metabolism ; Mice, Transgenic ; Fibrosis ; Cytokines/metabolism |
Chemical Substances | Cytokines |
Language | English |
Publishing date | 2024-01-11 |
Publishing country | Switzerland |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2606827-8 |
ISSN | 1664-3224 ; 1664-3224 |
ISSN (online) | 1664-3224 |
ISSN | 1664-3224 |
DOI | 10.3389/fimmu.2023.1302006 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.